Mitigation of Atherosclerotic Vascular Damage and Cognitive Improvement Through Mesenchymal Stem Cells in an Alzheimer’s Disease Mouse Model
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252313210 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Woong Jin Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Disease Models, Animal, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), Ministry of Education.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a neurodegenerative condition characterized by progressive memory loss and other cognitive disturbances. Patients with AD can be vulnerable to vascular damage, and damaged vessels can lead to cognitive impairment. Mesenchymal stem cell (MSC) treatment has shown potential in ameliorating AD pathogenesis, but its effect on vascular function remains unclear. This study aimed to improve cognitive function by alleviating atherosclerosis-induced vessel damage using MSCs in mice with a genetic AD background. In this study, a 5xFAD mouse model of AD was used, and atherosclerotic vessel damage was induced by high-fat diets (HFDs). MSCs were injected into the tail vein along with mannitol in 5xFAD mice on an HFD. MSCs were detected in the brain, and vascular damage was improved following MSC treatment. Behavioral tests showed that MSCs enhanced cognitive function, as measured by the Y-maze and passive avoidance tests. Additionally, muscle strength measured by the rotarod test was also increased by MSCs in AD mice with vessel damage induced by HFDs. Overall, our results suggest that stem cells can alleviate vascular damage caused by metabolic diseases, including HFDs, and vascular disease in individuals carrying the AD gene. Consequently, this alleviates cognitive decline related to vascular dementia symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, College of Medicine, Yonsei University, Seoul 03722, Republic of Korea.
- Department of Life Science, Kyonggi University, Suwon 16227, Republic of Korea.
ORCID-Profile: Woong Jin Lee, Kyoung Joo Cho, Gyung Whan Kim
Förderung
- National Research Foundation of Korea (NRF)
- Ministry of Education
Zitieren
APA
Lee, W. J., Cho, K. J., & Kim, G. W. (2024). Mitigation of Atherosclerotic Vascular Damage and Cognitive Improvement Through Mesenchymal Stem Cells in an Alzheimer’s Disease Mouse Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252313210
Vancouver
Lee WJ, Cho KJ, Kim GW. Mitigation of Atherosclerotic Vascular Damage and Cognitive Improvement Through Mesenchymal Stem Cells in an Alzheimer’s Disease Mouse Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252313210
BibTeX
@article{Lee2024,
author = {Lee, Woong Jin and Cho, Kyoung Joo and Kim, Gyung Whan},
title = {Mitigation of Atherosclerotic Vascular Damage and Cognitive Improvement Through Mesenchymal Stem Cells in an Alzheimer’s Disease Mouse Model},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252313210}
}
EUVIMED